Immunotherapy-associated autoimmune hemolytic anemia

BACKGROUND: Immunotherapy has been widely used in the treatment of several solid and hematologic malignancies. Checkpoint inhibitors have been the forefront of cancer immunotherapy in recent years. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death 1 (PD-1) pathway are th...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Uqba, Ali, Farman, Khurram, Muhammad Siddique, Zaka, Awais, Hadid, Tarik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319184/
https://www.ncbi.nlm.nih.gov/pubmed/28239468
http://dx.doi.org/10.1186/s40425-017-0214-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319184/
https://www.ncbi.nlm.nih.gov/pubmed/28239468
http://dx.doi.org/10.1186/s40425-017-0214-9

Ejemplares similares